# clm_2DB2351A5E3F

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: total_equity  
value: 9,525,300,000 United States dollar  
valid_from: 2009-12-31  
valid_to: 2010-03-31  
published: 2010-02-22  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_94E485E9D35E  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company total equity: 9,525,300,000 United States dollar", as of 2009-12-31 (until 2010-03-31). Claim clm_2DB2351A5E3F, https://asof.is/claim/clm_2DB2351A5E3F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000095012310014958/0000950123-10-014958-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2009, filed 2010-02-22  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000095012310014958/0000950123-10-014958-index.htm (primary, SEC EDGAR 10-K FY2009, published 2010-02-22)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 9,905,000,000 United States dollar | valid 2009-09-30 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_2DB2351A5E3F](/claim/clm_2DB2351A5E3F.md) | [clm_76B236DB1A35](/claim/clm_76B236DB1A35.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.